of
LEXINGTON, Ky. (April 12, 2021) With COVID-19 vaccinations continuing to roll out across the country, the University of Kentucky Markey Cancer Center strongly encourages both cancer survivors, caregivers and patients in active cancer treatment to receive one of the available vaccines. This is in line with recommendations from both the Centers for Disease Control and Prevention (CDC) and the American Cancer Society.
As of Monday, April 5, any Kentuckian age 16 and up is eligible to get the Pfizer vaccine. The Moderna and Johnson & Johnson vaccines are available to anyone age 18 and older. Given the higher rates of severe COVID-19 infection in cancer patients, the American Society of Clinical Oncology and the CDC recommend that cancer patients strongly consider vaccination against COVID-19, said Dr. Frederick R. Ueland, gynecologic oncologist and director of oncology clinical operations at the UK Markey Cancer Center. This includes cancer survivors, most patients undergo